Does AMBRISENTAN Cause Pulmonary embolism? 211 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 211 reports of Pulmonary embolism have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.2% of all adverse event reports for AMBRISENTAN.
211
Reports of Pulmonary embolism with AMBRISENTAN
0.2%
of all AMBRISENTAN reports
41
Deaths
161
Hospitalizations
How Dangerous Is Pulmonary embolism From AMBRISENTAN?
Of the 211 reports, 41 (19.4%) resulted in death, 161 (76.3%) required hospitalization, and 6 (2.8%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 211 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which AMBRISENTAN Alternatives Have Lower Pulmonary embolism Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE